Merit Financial Group, LLC Bausch Health Companies Inc. Transaction History

Merit Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$5.72 - $8.8 $13,911 - $21,401	2,432 Added 9.44%	28,204 $225,000
Q1 2023 Apr 24, 2023	BUY	$6.28 - $9.85 $7,422 - $11,642	1,182 Added 4.81%	25,772 $208,000
Q4 2022 Jan 13, 2023	SELL	$6.09 - $7.93 $30,450 - $39,650	-5,000 Reduced 16.9%	24,590 $0
Q3 2022 Oct 31, 2022	BUY	$4.58 - $9.21 $135,522 - $272,523	29,590 New	29,590 $204,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Merit Financial Group, LLC with notifications on news.